These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25302847)

  • 1. Angiotensin II in inflammation, immunity and rheumatoid arthritis.
    Chang Y; Wei W
    Clin Exp Immunol; 2015 Feb; 179(2):137-45. PubMed ID: 25302847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative Stress in Autoimmune Diseases: An Under Dealt Malice.
    Ramani S; Pathak A; Dalal V; Paul A; Biswas S
    Curr Protein Pept Sci; 2020; 21(6):611-621. PubMed ID: 32056521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunometabolism: an overview and therapeutic prospects in autoimmune diseases.
    Stathopoulou C; Nikoleri D; Bertsias G
    Immunotherapy; 2019 Jun; 11(9):813-829. PubMed ID: 31120393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
    El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
    Front Immunol; 2021; 12():643170. PubMed ID: 33732263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.
    Abou-Raya A; Abou-Raya S
    Autoimmun Rev; 2006 May; 5(5):331-7. PubMed ID: 16782558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpesviruses and autoimmunity.
    Posnett DN
    Curr Opin Investig Drugs; 2008 May; 9(5):505-14. PubMed ID: 18465661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights into the Management of Patients with Autoimmune Diseases or Inflammatory Disorders During Pregnancy.
    Tavakolpour S; Rahimzadeh G
    Scand J Immunol; 2016 Sep; 84(3):146-9. PubMed ID: 27300757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer Oligonucleotides: Novel Potential Therapeutic Agents in Autoimmune Disease.
    Li W; Lan X
    Nucleic Acid Ther; 2015 Aug; 25(4):173-9. PubMed ID: 25993618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural products action on pathogenic cues in autoimmunity: Efficacy in systemic lupus erythematosus and rheumatoid arthritis as compared to classical treatments.
    Cao F; Cheng MH; Hu LQ; Shen HH; Tao JH; Li XM; Pan HF; Gao J
    Pharmacol Res; 2020 Oct; 160():105054. PubMed ID: 32645358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis.
    Alaaeddine N; Hassan GS; Yacoub D; Mourad W
    Clin Dev Immunol; 2012; 2012():490148. PubMed ID: 22110533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 update.
    Kubo S; Nakayamada S; Tanaka Y
    Expert Rev Clin Immunol; 2019 Jul; 15(7):693-700. PubMed ID: 30987474
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of toll-like receptor function has therapeutic potential in autoimmune disease.
    Clanchy FI; Sacre SM
    Expert Opin Biol Ther; 2010 Dec; 10(12):1703-16. PubMed ID: 21039312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathogenesis of systemic lupus erythematosus and rheumatoid arthritis: the role of aberrant expression of non-coding RNAs in T cells.
    Lai NS; Koo M; Yu CL; Lu MC
    Clin Exp Immunol; 2017 Mar; 187(3):327-336. PubMed ID: 27880973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis.
    Santos LL; Morand EF
    Clin Chim Acta; 2009 Jan; 399(1-2):1-7. PubMed ID: 18838066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I interferon in organ-targeted autoimmune and inflammatory diseases.
    Crow MK
    Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S5. PubMed ID: 21303493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus.
    Kahlenberg JM; Kaplan MJ
    Annu Rev Med; 2013; 64():249-63. PubMed ID: 23020882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date.
    Lazzerini PE; Capecchi PL; Guidelli GM; Selvi E; Acampa M; Laghi-Pasini F
    Drug Des Devel Ther; 2016; 10():3083-3098. PubMed ID: 27713619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicles in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Functions and Applications.
    Zhang B; Zhao M; Lu Q
    Front Immunol; 2020; 11():575712. PubMed ID: 33519800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of leptin in rheumatoid arthritis.
    Tian G; Liang JN; Wang ZY; Zhou D
    Clin Exp Immunol; 2014 Sep; 177(3):557-70. PubMed ID: 24802245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin system molecules are associated with subclinical atherosclerosis and disease activity in rheumatoid arthritis.
    Braz NFT; Pinto MRC; Vieira ÉLM; Souza AJ; Teixeira AL; Simões-E-Silva AC; Kakehasi AM
    Mod Rheumatol; 2021 Jan; 31(1):119-126. PubMed ID: 32149558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.